Press releases about „constipation“ sorted by

Date of release

• Date of release
• Relevance

Search: press release constipation

ENHERTU® Achieved a Tumor Response Rate of 45.3% in Patients with HER2 Positive Metastatic Colorectal Cancer in Phase 2 DESTINY-CRC01 Trial

• 2020-05-29
• Medical Technology
• DAIICHI SANKYO EUROPE GmbH

Results from the phase 2 DESTINY-CRC01  trial of Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca’s ENHERT­U®     (fam-trastuzumab deruxtecan-nxki) demonstrated clinically meaningful activity in patients with HER2 positive unresectable and/or metastatic colorectal cancer who received at least two prior lines of standard treatment.... go to the press release

---

Search: press release constipation

ENHERTU® Significantly Improved Tumor Response Rate and Overall Survival in HER2 Positive Metastatic Gastric Cancer in Pivotal Phase 2 DESTINY-Gastric01 Trial

• 2020-05-29
• Medical Technology
• DAIICHI SANKYO EUROPE GmbH

First HER2 directed therapy to show an improvement in overall survival for previously-treated metastatic gastric cancer with a 41% reduction in the risk of death versus chemotherapy Breakth­rough Therapy Designation recently granted in the U.S. for ENHERTU in this setting Detailed results from the positive pivotal randomized, controlled phase 2 DESTINY-Gastric01... go to the press release

---

Search: press release constipation

ENHERTU® Demonstrated Meaningful Clinical Activity in Patients with HER2 Mutant Non-Small Cell Lung Cancer in Interim Analysis of Phase 2 DESTINY-Lung01 Trial

• 2020-05-29
• Medical Technology
• DAIICHI SANKYO EUROPE GmbH

9% of patients with HER2 mutant metastatic non-small cell lung cancer treated with ENHERTU achieved a tumor response Breakthroug­h Therapy Designation recently granted in the U.S. in this setting Results from the ongoing phase 2 DESTINY-Lung01 trial showed Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca’s ENHERTU® (fam-trastuzumab... go to the press release

---

Search: press release constipation

Chronic Idiopathic Constipation Market Highest CAGR of 7.4% with Key Venders by 2023

• 2019-01-04
• Software
• MRFR

Chronic Idiopathic Constipation Market - Key Players Some of the key players in this market are  Actavis (U.S.), Chugai Pharmaceutical (Japan), Ferring International Center S.A.(Switzerland), Synergy Pharmaceuticals (U.S.), Pfizer Inc (U.S.), GlaxoSmithKline (U.K.), Sanofi (France), Bayer (Germany), Salix Pharmaceuticals Ltd (U.S.), Sucampo Pharmaceuticals... go to the press release

---

Search: press release constipation

Dyspepsia Market 2018 Global Trend, Segmentation and Opportunities Forecast To 2023

• 2018-10-30
• Software
• MRFR

Market Scenario The global dyspepsia market is expected to witness a positive growth during the forecast period. Dyspepsia is a chronic medical condition, that causes discomfort in the upper abdomen of the patient due to indigestion. The gastrointestinal organs, the stomach and the small intestine (sometimes the esophagus), do not function normally.... go to the press release

---

Search: press release constipation

Laxatives Market - Granular Market Report and Review, 2018

• 2018-10-20
• Software
• MRFR

Market Scenario: Laxative­s are drugs used in the treatment of constipation and to promote evacuation of bowels by increase bowel movements. Although there is a difference in their mechanism of action but all laxatives increase the water content of faeces and thereby ease their removal. The market for laxatives is a bloated market with the growing... go to the press release

---

Search: press release constipation

Anal Fissure Treatment Market Value Share, Supply Demand, share and Value Chain 2018

• 2018-10-19
• Software
• MRFR

An expert on premium research reports, Market Research Future has added a report titled " Anal Fissure Treatment Market Research Report- Global Forecast till 2023" to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top Market Players across the Globe.   The global... go to the press release

---

Search: press release constipation

Anorectal Manometry Systems Market : Global Trends, Analysis and Forecast 2028

• 2018-05-24
• Medical Technology
• Future Market Insights

Anorectal manometry systems are adopted for evaluation of patients suffering from fecal incontinence, constipation or any other disorders related to lower gastrointestinal tract, which may involve anorectal sphincter. An anorectal manometry system measures the capability of the anal sphincter muscles to apply pressure in the rectum and also measures... go to the press release

---

Search: press release constipation

Anorectal Manometry Systems Market Estimated to Experience a Hike in Growth by 2028

• 2018-05-22
• Research / Development
• Future Market Insights

Anorectal manometry systems are adopted for evaluation of patients suffering from fecal incontinence, constipation or any other disorders related to lower gastrointestinal tract, which may involve anorectal sphincter. An anorectal manometry system measures the capability of the anal sphincter muscles to apply pressure in the rectum and also measures... go to the press release

---

Search: press release constipation

Clinical Studies: Bowel function

• 2014-10-13
• Biotechnology
• BioTeSys GmbH

Bowel function Constipation is one of the most common health impairments in Western countries. Its prevalence is widely variable, depending on criteria utilized for diagnosis. Usually constipated patients have mild to moderate symptoms which are predominantly self-treated. For that reason the digestive tract and its function are promising targets... go to the press release